Vascular Biology of Diabetes

Slides:



Advertisements
Similar presentations
What Causes Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes? Charles A. Reasner, MD Professor of Medicine University of.
Advertisements

Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
Pathophysiology of Hypertension Tatár M. Dept. of Pathophysiology Jessenius Med. School.
Faculty Disclosure Amy J. Arouni, MD, FACC Dr. Arouni has listed no financial interest/arrangement that would be considered a conflict of interest.
Biochemistry of Endothelial Cells Doc. Dr. Mine KUCUR.
Text 1 Biochemistry of Glucose Damage in Diabetes.
Diabetes mellitus complications & morphology. Complications of diabetes  In type 1 &2 diabetes  Variable onset, severity,organs of involvement  Macrovascular.
S-KHALILZADEH. BIOCHEMISTRY AND MOLECULAR CELL BIOLOGY All forms of diabetes, both inherited and acquired, are characterized by hyperglycemia, a relative.
Journal Reading Myocardial infarction in young people Cardiol J 2009; 16, 4: 307–311 Cardiol J 2008; 15: 21–25 Presented by R 王郁菁 at ER conference.
Adiposity in CVD. Role of adipose tissue in atherogenesis Adapted from de Luca C, Olefsky JM. Nat Med. 2006;12:41-2. Lau DCW et al. Am J Physiol Heart.
It’s ALIVE: Atherogenesis, a Dynamic Inflammatory Process Kathy Robinson, PhD, RN, CCNS University of North Florida School of Nursing NTI, New Orleans,
Aging of the Cardiovascular System (continued)
MCB 135K: Discussion.
ATHEROSCLEROSIS. Atherosclerosis Atherosclerosis is a disease of large and medium-sized muscular arteries and is characterized by endothelial dysfunction,
Diabetic Retinopathy Steven Sanislo, M.D. Assistant Professor Stanford University Department of Ophthalmology.
Goals: 1) Understand the mechanism for ↑LDL in Type II diabetes 2) Having previously established the link between endothelial cell damage (loss of inhibitory.
Therapy of Type 2 Diabetes Mellitus: UPDATE
Exams & Grading: 85% of the final grade: Exam scores from each of the three Sections will represent one-third of a total of 85% of the final grade for.
Chp101 Oxidative stress, inflammation, and diabetes complications.
Hyperglycemia at the Vessel Wall. Potential hyperglycemia-induced tissue damage Brownlee M. Diabetes. 2005;54: Repeated acute changes in cellular.
Liberty Medical. Microvascular and Macrovascular.
Reem Sallam, MD, MSc. PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
Dr. Amr S. Moustafa, MD, PhD Clinical Chemistry Unit, Pathology Dept. College of Medicine, King Saud University.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
Ischemia-Reperfusion injury Su Chang Fu 90/6/19. Ischemia Anesthesiologist: MI, peripheral vascular insufficiency, stroke, and hypovolemic shock Restoration.
ENDOTHELIAL DYSFUNCTION - ED A Marker of Cardio Vascular Disease
VBWG Insulin Resistance and Cardiovascular Disease: New Perspectives From Vascular Biology.
ATHEROSCLEROSIS Dr: Wael H.Mansy, MD Assistant Professor
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Dr. Hany Ahmed Assistant Professor of Physiology (MD, PhD) Al Maarefa Colleges (KSA) & Zagazig University (EGY) Specialist of Diabetes, Metabolism and.
What do we know about preeclampsia?. Preeclampsia: a two stage disorder Stage 1: Reduced Placental perfusion abnormal implantation Stage 2: Maternal Syndrome.
Pathogenesis of Cerebral Infarction at Cellular & Molecular Levels By: Reem M Sallam, MD, PhD.
Diabetes Complications and Control Trial (DCCT) Tight control of blood glucose levels significantly decreased risk of diabetic complications. Finding.
Ischemic Heart Disease Dr. Ravi Kant Assistant Professor Department of General Medicine.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
Hyperglycemia The Defining Feature of Diabetes
“Neurovascular Coupling Research". Am J Physiol Heart Circ Physiol Aug;285(2):H Am J Physiol Heart Circ Physiol Aug;285(2):H (PMID:
Cardiovascular pathophysiology III
Overview of advanced glycation end-products (AGEs) Part 2
Chemical Mediators and Regulators of Inflammation 1 Dr. Hiba Wazeer Al Zou’bi.
ATHEROSCLEROSIS. Institute of Pathological Physiology Martin Vokurka Winter Semester 2007/08.
بسم الله الرحمن الرحيم.
Source: International Chair on Cardiometabolic Risk Metabolic Syndrome and Adipose Tissue Yuji Matsuzawa, MD, PhD Director.
Soluble Klotho Pretreatment Improves Endothelial Dysfunction Induced By FGF23 Halee Patel, Neerupma Silswal, and Michael Wacker UMKC School of Medicine,
Venous Thromboembolism-1
Is atherosclerosis a metabolic disease?
بسم الله الرحمن الرحيم.
Metabolic Changes in Diabetes Mellitus
Metabolic Changes in Diabetes Mellitus
Dr. Mohammad Alkhowaiter, MD Consultant Nephrologist
Section II: A primer on the endothelium
Section 3: Role of lipids in endothelial function
Chemical Mediators Dr Shoaib Raza.
In Metabolic Syndrome Hyperinsulinism Creates the Vicious Cycle: Increased MAP-kinase pathway Circulation. 2005;111: Metabolic Syndrome A Comprehensive.
Focus: Lipids and the endothelium
Section I: RAS manipulation
Advanced Nutrition Diet and Cardiovascular Disease 1
Vascular endothelial dysfunction in cirrhosis
The marriage of glucose and blood vessels: It isn’t all that sweet
Endothelial cell dysfunction and nitric oxide synthase
Nat. Rev. Nephrol. doi: /nrneph
Diabetes and atherosclerosis
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Endothelial function: Changing the pattern of treating CV disease
Dr. Mohammad Alkhowaiter, MD Consultant Nephrologist
Figure 2 Protective functions of HDL
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Endothelial regulation: Understanding RAS
Impaired Lung Function and Risk for Stroke
Christian Rask-Madsen, George L. King  Cell Metabolism 
Presentation transcript:

Vascular Biology of Diabetes Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University Oct . 15 . 2003

Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction (ED). Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia / insulin resistance and ED .

Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction. Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia / insulin resistance and ED .

Cardiovascular Diseases Diabetes Mellitus Independent major risk factor Accelerated atherosclerosis morbidity & mortality (80 %) Cardiovascular Diseases

Acute Hyperglycemia Normal Volunteers Rapid BP elevation Glucose levels trigger functional alterations in vasomotor motions Marfella et al . Am J Physiol Endocrinol Metab . 1995 , 268 : E 1167 -

Diabetic Microangiopathy At later stages At early stage Reversible changes : Capillary press . Blood flow . EC permeability . Irrevesible changes : Thickening of the basement membrane Extracellular accumulation of proteins Arosio et al . Ann Ital Med Int . 1999 ; 14 (2) : 106-

Arosio et al . Ann Ital Med Int . 1999 ; 14 (2) : 106 The onset of microvascular lesions in diabetes has been preceded by endothelial dysfunction manifestations: * ( ) in the vasodilatation response to vasoactive agents . * Alterations in the antithrombotic properties. Arosio et al . Ann Ital Med Int . 1999 ; 14 (2) : 106

Pomilio et al . I pediatr Endocrinol Metab .2002 ; 15(4): 343- In diabetic patients E N D O T H L I U M The primary target of unbalanced glycemic control. Involved in the pathogenesis of vascular complications. Pomilio et al . I pediatr Endocrinol Metab .2002 ; 15(4): 343-

Endothelial pathophysiologic balance Vasodilators Nitric oxide Prostacyclin Endothelium derived hyperpolarizing factor C-natriuretic peptide Antithrombotic Tissue type plasminogen activator Growth inhibitors Inflammation inhibitors Vasoconstrictors Endothelin-1 Angiotensin II Endoperoxide (PGH2) Thromboxane A2 Prothrombotic Plasminogen activator inhibitor-1 Growth promotors Superoxide radicals Endothelin Angiotenisn II Inflammation promotors Superoxide and other free radicals Tumor necrosis factor-alpha

The concept of Endothelial Dysfunction. Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction. Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia / insulin resistance and ED .

IMPAIRED VASORELAXATION Hyperglycemia Advanced Glycosylation End Products Oxidized Lipoproteins Insulin Resistance INCREASED PROTHROMBOTIC ACTIVITY Leukocyte adhesion molecules & chemoattractants Cell surface procoagulant activity Altered junctions & transport EDRF PGI2 Expression of growth factors & mitogens INCREASED PERMEABILITY & TRAPPING of LDL IMPAIRED VASORELAXATION (VASOSPASM) INCREASED LEUKOCYTE RECRUITMENT SMC MIGRATION, PROLIFERATION & ECM PRODUCTION

Goligorsky et al . Hypertension .2001, 37 [part2] : 744-748. “ EC - dependent vasorelaxation ( flow - mediated dilatation )by using echo Doppler has remained the gold standard in assessing endothelial function & dysfunction .” Goligorsky et al . Hypertension .2001, 37 [part2] : 744-748.

Endothelial Nitric Oxide Production GTP VSMc c GMP SM relaxation (+) Guanylyl cyclase TARGET CELLS (SMC, EC, PLATELETS) [NO/EDRF] LSS Growth Factors Acetylcholine (other mediators) LSS L-arg [Ca+2, IP3] ecNOS ecNOS L-arginine citrulline ACUTE CHRONIC

Mechanisms of ED in diabetes:- Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction. Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia / insulin resistance and ED .

Goligorsky et al . Hypertension .2001; 37 [part2] : 744 Proposal consequence ( transient & cumulative) of hyperglycmic episodes on vascular wall . Goligorsky et al . Hypertension .2001; 37 [part2] : 744

“ The ED initiation events is linked to scavenging of NO by glucose ( NO bioavailability ) during transient episodes of hyperglycemia ”

Acute Hypertensive response (-) Vasorelaxation 15 min. after hyperglycemia NO Bioavailability (+) Platelet reactions prothrmbotic activity (+) (MN) leukocyte chemotaxis & activation (+) Express . of leukocyte - CAMs (+) VSMC migration & proliferation Acceleration of Atherosclerosis Brodsky et al . Am J Physiol Renal Physiol . 2001; 280: F 480-

NO scavenging (Chronic)

Mechanisms of ED in diabetes:- Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction. Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia / insulin resistance and ED .

ROS + NO Acute Hyperglycemia NO Bioavailability In healthy subjects (+) Mitochondrial superoxide (O2.-) production ROS + NO Peroxynitrites (ineffective) Plasma nitrotyrosine (marker of oxid . Stress ) NO Bioavailability Marfella et al . JCI . 2001 , 108 (4) : 635

Hyperglycemia in Diabetes Tissue deposition Hyperglycemia in Diabetes Aging Ambient glucose Non-enzymatic reaction Primary amino acid groups on protein Maillard reaction Amadoric products Dehydration Fragmentation AGEs in the Sub-EC Compartment Friedman . Nephrol Dial Transport . 1999; 14 [Suppl 3] : 1-9

AGEs ROS NO Bioavailability Bind with their receptors RAGE (EC, VSMC, Macrophages) Quench NO activity ROS NO Bioavailability Tan et al . Diabetic Care . 2002; 25 (6): 1055

AGE - RAGE interaction is a potential source for cell-mediated oxidation & lipid peroxidation

Oxidative-modification hypothesis Diaz et al. NEJM. 1997,337(6) : 408

Hyperglycemia NO Bioavailability Protein kinase C (PKC) activation Glucose – induced O2.- Mitochondrial O2.-over Diacylglycerol (DAG) Protein kinase C (PKC) activation (-) PI3 kinase- mediated eNOS(+) (+) NAD(P) H oxidase ROS NO Bioavailability Beckman et al . Circ Res . 2002 ; 90 : 107-

Mechanisms of ED in diabetes:- Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction. Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia / insulin resistance and ED .

AGEs Consume EC-derived NO Functional NO deficiency Deficiency of Quench NO Activity Functional NO deficiency Deficiency of Angiogenic response (+) fibroblast proliferation Extracellular matrix & physico-chemical changes Collagen -to- collagen cross linking & tissue rigidity Vascular Complications of Diabetes Goligorsky et al . Hypertension . 2001 ; 37 [part 2]

Proposed pathophysiological mechanisms acting during maintenance phase of ED .

Tan et al . Diabetic care . 2002 ; 25(6) : 1055 (+) (+) Induction of TGF - b “chemotactic factor” AGEs NF- kB (+) VSMC migration ( ) ET-1 prod. Atherosclerosis (+) Hyperglycemia Tan et al . Diabetic care . 2002 ; 25(6) : 1055

Clinical manifestations of diabetic nephropathy and potenial role of ED

Hyperinsulinemia/insulin resistance and ED . Diabetes is a Cardiovascular disease. The concept of Endothelial Dysfunction. Mechanisms of ED in diabetes:- Initiation ( trigger ) phase of ED: (Hyperglycemia - induced ED) Transition from initiation to maintenance phase of ED: (Formation of AGEs) Maintenance phase of ED: (Tightly linked to accumulation of AGEs) Hyperinsulinemia/insulin resistance and ED .

Metabolic Syndrome Cluster of Metabolic & CV Abnormalities Endothelium Insulin Resistance Endothelium Target of Insulin’s action on vasomotility Common dominator

Insulin Protective effects Deleterious effects (-) apoptosis (+) NO prod. (+)VEGF . (+) ET-1 . Salt - sensitive HTN * Vicent et al . TCI . 2003 , III (9) : 1373- * Ogihara et al . Diabetes . 2001 , 50 : 573-

Insulin Resistance (+) PKC in vascular tissues (-) PI-3 Kinase (-) eNOS express. Modulates vascular tone Kuboki et al Circulation . 2000 ; 101 : 676 -

O2.- ED Vit. C Hyperinsulinemia (-) EC- dependent VD (+) E T-1 Prolonged exposure (-) EC- dependent VD (+) ED Vit. C O2.- (Antioxidant) (+) NAD(P) H oxidase express . (+) E T-1 Arcaro et al . Circulation . 2002 ; 105 : 576

Conclusion Diabetes is a chronic vascular disease in which disordered glucose homeostasis triggers endothelial dysfunction of every organ, deriving, in part, from vascular disturbance.

Glycemic control (-) macrovascular & microvascular diseases (+) microvascular & macrovascular complications Glycemic control (-) macrovascular & microvascular diseases Gerich . Arch Intern Med . 2003 . 9 ; 16B (11) : 1306

Conclusion Understanding the mechanism(s) by which acute hyperglycemia induces ED in DM may lead to secondary preventive strategies to reduce CV morbidity and mortality in this highly prevalent disease .